Muristerone ATRAIL- and hFasL-induced apoptosis inhibitor CAS# 38778-30-2 |
- PSI-7977
Catalog No.:BCC1871
CAS No.:1190307-88-0
- Trovafloxacin mesylate
Catalog No.:BCC3931
CAS No.:147059-75-4
- Capecitabine
Catalog No.:BCN2168
CAS No.:154361-50-9
- Viomycin
Catalog No.:BCC3930
CAS No.:32988-50-4
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 38778-30-2 | SDF | Download SDF |
| PubChem ID | 122217 | Appearance | Powder |
| Formula | C27H44O8 | M.Wt | 496.63 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | Mur A | ||
| Solubility | Soluble in DMSO > 10 mM | ||
| Chemical Name | (2S,3R,5S,9R,10R,11R,13R,14S,17S)-17-[(2R,3R)-2,3-dihydroxy-6-methylheptan-2-yl]-2,3,5,11,14-pentahydroxy-10,13-dimethyl-1,2,3,4,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-6-one | ||
| SMILES | CC(C)CCC(C(C)(C1CCC2(C1(CC(C3C2=CC(=O)C4(C3(CC(C(C4)O)O)C)O)O)C)O)O)O | ||
| Standard InChIKey | LRJUYAVTHIEHAI-LHBNDURVSA-N | ||
| Standard InChI | InChI=1S/C27H44O8/c1-14(2)6-7-20(31)25(5,33)19-8-9-26(34)15-10-21(32)27(35)13-17(29)16(28)11-24(27,4)22(15)18(30)12-23(19,26)3/h10,14,16-20,22,28-31,33-35H,6-9,11-13H2,1-5H3/t16-,17+,18+,19-,20+,22+,23+,24+,25+,26+,27+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Ecdysone analog that acts as an inducer of ecdysone-inducible gene expression systems in mammalian cells and transgenic animals. Stimulates Bcl-XL mRNA transcription and inhibits TRAIL- and hFasL-induced apoptosis in RKO cells. |
Muristerone A Dilution Calculator
Muristerone A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.0136 mL | 10.0679 mL | 20.1357 mL | 40.2714 mL | 50.3393 mL |
| 5 mM | 0.4027 mL | 2.0136 mL | 4.0271 mL | 8.0543 mL | 10.0679 mL |
| 10 mM | 0.2014 mL | 1.0068 mL | 2.0136 mL | 4.0271 mL | 5.0339 mL |
| 50 mM | 0.0403 mL | 0.2014 mL | 0.4027 mL | 0.8054 mL | 1.0068 mL |
| 100 mM | 0.0201 mL | 0.1007 mL | 0.2014 mL | 0.4027 mL | 0.5034 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Muristerone A is a natural analog of 20-hydroxyecdysone. It is an agonist of the ecdysteroid receptor (Kd = 1 nM), a nuclear receptor that heterodimerizes with a retinoid X receptor ortholog and regulates arthropod development. Muristerone A is used as an agonist in ecdysone-inducible gene expression systems in mammalian cells. However, it inhibits apoptosis in the human colon carcinoma cell line RKO by inducing the upregulation of Bcl-xL, suggesting limitations in its use in certain types of studies.
- Tetrahydroisocucurbitacin I
Catalog No.:BCN7874
CAS No.:3877-89-2
- Cucurbitacin D
Catalog No.:BCN2355
CAS No.:3877-86-9
- Swazine
Catalog No.:BCN2143
CAS No.:38763-74-5
- Worenine
Catalog No.:BCN2557
CAS No.:38763-29-0
- Triptolide
Catalog No.:BCN5984
CAS No.:38748-32-2
- 3-Epibetulinic acid
Catalog No.:BCN8531
CAS No.:38736-77-5
- Seneciphylline N-oxide
Catalog No.:BCN5439
CAS No.:38710-26-8
- Preskimmianine
Catalog No.:BCN6667
CAS No.:38695-41-9
- Groenlandicine
Catalog No.:BCN8189
CAS No.:38691-95-1
- DAPK Substrate Peptide
Catalog No.:BCC2400
CAS No.:386769-53-5
- Desvenlafaxine Succinate
Catalog No.:BCC5048
CAS No.:386750-22-7
- Neodiosmin
Catalog No.:BCN8337
CAS No.:38665-01-9
- Tectoruside
Catalog No.:BCN8262
CAS No.:38784-73-5
- Tandutinib (MLN518)
Catalog No.:BCC4499
CAS No.:387867-13-2
- Lapatinib Ditosylate
Catalog No.:BCC2083
CAS No.:388082-78-8
- Emodin-1-O-glucoside
Catalog No.:BCN8512
CAS No.:38840-23-2
- Tetrahydroepiberberine
Catalog No.:BCN2649
CAS No.:38853-67-7
- PSN 375963 hydrochloride
Catalog No.:BCC7663
CAS No.:388575-52-8
- CK 869
Catalog No.:BCC6347
CAS No.:388592-44-7
- Z-Glu(OtBu)-OH
Catalog No.:BCC2776
CAS No.:3886-08-6
- Halaminol A
Catalog No.:BCN1788
CAS No.:389125-56-8
- Halaminol B
Catalog No.:BCN1748
CAS No.:389125-59-1
- Halaminol C
Catalog No.:BCN1787
CAS No.:389125-68-2
- erythro-Guaiacylglycerol
Catalog No.:BCN5440
CAS No.:38916-91-5
Muristerone A-induced nerve growth factor release from genetically engineered human dermal fibroblasts for peripheral nerve tissue engineering.[Pubmed:11429150]
Tissue Eng. 2001 Jun;7(3):303-11.
In this study, human dermal fibroblasts (hDFBs) were genetically modified to release human nerve growth factor (NGF) using an ecdysone-inducible system. NGF cDNA was inserted into the pIND vector and then hDFBs were cotransfected with pIND-NGF and pVgRXR. Muristerone A, an analog of ecdysone, was used as the inducing agent. NGF release from transfected hDFBs was assessed in vitro and in vivo. Transfected hDFBs in the presence of Muristerone A possessed a maximal in vitro release of 8.5 +/- 0.4 pg of NGF/mL per 10(3) cells, demonstrating significantly higher NGF levels compared to control hDFBs. The in vitro release rate curve for transfected hDFBs in the presence of Muristerone A exhibited a maximum of 5.1 +/- 0.2 ng NGF/10(6) cells/day. A PC-12 bioassay demonstrated that the in vitro NGF released is bioactive. When transfected hDFBs in the presence of Muristerone A were placed in vivo in nude rats, NGF levels reach 2074 +/- 257 pg/mL and 1620 +/- 132 pg/mL at 24 and 48 h, respectively. These levels were significantly higher than negative control and wound fluid levels. Results support further in vivo investigation of this molecular "on" switch for peripheral nerve regeneration.
The ecdysone inducible gene expression system: unexpected effects of muristerone A and ponasterone A on cytokine signaling in mammalian cells.[Pubmed:11399528]
Eur Cytokine Netw. 2001 Apr-Jun;12(2):365-7.
Inducible gene expression systems in mammalian cells have been shown to be valuable processes to study the specific function of a protein in differentiation, proliferation or survival/apoptosis. Usually, these systems use as inducible reagents, compounds that are thought to be neutral and devoid of physiological or biologically undesirable effects in mammalian cells. We recently used the ecdysone inducible gene expression system in hematopoietic cells and found that the two inducer analogs of ecdysone, Muristerone A and ponasterone A, altered the signaling pathways induced by IL-3 in the pro-B cell-line, Ba/F3. Indeed, we showed that these two analogs potentiate the IL-3-dependent activation of the PI 3-kinase/Akt pathway, which could ultimately interfere with the growth, and/or survival of these cells.
